• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care

tetano

Editor, Senior Moderator
Nat Commun


. 2021 Jun 7;12(1):3406.
doi: 10.1038/s41467-021-23494-1.
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care


Clemens Gutmann[SUP] #[/SUP][SUP] 1 [/SUP], Kaloyan Takov[SUP] #[/SUP][SUP] 1 [/SUP], Sean A Burnap[SUP] #[/SUP][SUP] 1 [/SUP], Bhawana Singh[SUP] #[/SUP][SUP] 1 [/SUP], Hashim Ali[SUP] #[/SUP][SUP] 1 [/SUP], Konstantinos Theofilatos[SUP] 1 [/SUP], Ella Reed[SUP] 1 [/SUP], Maria Hasman[SUP] 1 [/SUP], Adam Nabeebaccus[SUP] 1 2 [/SUP], Matthew Fish[SUP] 3 4 [/SUP], Mark Jw McPhail[SUP] 2 5 6 [/SUP], Kevin O'Gallagher[SUP] 1 2 [/SUP], Lukas E Schmidt[SUP] 1 [/SUP], Christian Cassel[SUP] 1 [/SUP], Marieke Rienks[SUP] 1 [/SUP], Xiaoke Yin[SUP] 1 [/SUP], Georg Auzinger[SUP] 2 [/SUP], Salvatore Napoli[SUP] 5 [/SUP], Salma F Mujib[SUP] 6 [/SUP], Francesca Trovato[SUP] 2 5 6 [/SUP], Barnaby Sanderson[SUP] 4 [/SUP], Blair Merrick[SUP] 7 [/SUP], Umar Niazi[SUP] 8 [/SUP], Mansoor Saqi[SUP] 8 [/SUP], Konstantina Dimitrakopoulou[SUP] 8 [/SUP], Rafael Fernández-Leiro[SUP] 9 [/SUP], Silke Braun[SUP] 10 [/SUP], Romy Kronstein-Wiedemann[SUP] 11 [/SUP], Katie J Doores[SUP] 3 [/SUP], Jonathan D Edgeworth[SUP] 3 7 [/SUP], Ajay M Shah[SUP] 1 2 [/SUP], Stefan R Bornstein[SUP] 12 13 [/SUP], Torsten Tonn[SUP] 11 14 [/SUP], Adrian C Hayday[SUP] 3 15 [/SUP], Mauro Giacca[SUP] 1 [/SUP], Manu Shankar-Hari[SUP] 16 17 [/SUP], Manuel Mayr[SUP] 18 19 [/SUP]



Affiliations

Abstract

Prognostic characteristics inform risk stratification in intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). We obtained blood samples (n = 474) from hospitalized COVID-19 patients (n = 123), non-COVID-19 ICU sepsis patients (n = 25) and healthy controls (n = 30). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA was detected in plasma or serum (RNAemia) of COVID-19 ICU patients when neutralizing antibody response was low. RNAemia is associated with higher 28-day ICU mortality (hazard ratio
, 1.84 [95% CI, 1.22-2.77] adjusted for age and sex). RNAemia is comparable in performance to the best protein predictors. Mannose binding lectin 2 and pentraxin-3 (PTX3), two activators of the complement pathway of the innate immune system, are positively associated with mortality. Machine learning identified 'Age, RNAemia' and 'Age, PTX3' as the best binary signatures associated with 28-day ICU mortality. In longitudinal comparisons, COVID-19 ICU patients have a distinct proteomic trajectory associated with mortality, with recovery of many liver-derived proteins indicating survival. Finally, proteins of the complement system and galectin-3-binding protein (LGALS3BP) are identified as interaction partners of SARS-CoV-2 spike glycoprotein. LGALS3BP overexpression inhibits spike-pseudoparticle uptake and spike-induced cell-cell fusion in vitro.
 
Back
Top Bottom